avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Batf | mm10_v2_chr12_+_85686648_85686702 | 0.60 | 1.0e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142661858 Show fit | 7.99 |
ENSMUST00000145896.2
|
insulin-like growth factor 2 |
|
chr7_-_142661305 Show fit | 7.75 |
ENSMUST00000105936.1
|
insulin-like growth factor 2 |
|
chr3_-_123034943 Show fit | 2.96 |
ENSMUST00000029761.7
|
myozenin 2 |
|
chr14_-_33185489 Show fit | 2.58 |
ENSMUST00000159606.1
|
WD repeat and FYVE domain containing 4 |
|
chr13_-_21780616 Show fit | 2.50 |
ENSMUST00000080511.2
|
histone cluster 1, H1b |
|
chr2_+_164948219 Show fit | 2.15 |
ENSMUST00000017881.2
|
matrix metallopeptidase 9 |
|
chr7_-_45211877 Show fit | 1.91 |
ENSMUST00000033057.7
|
dickkopf-like 1 |
|
chr5_-_44099220 Show fit | 1.54 |
ENSMUST00000165909.1
|
prominin 1 |
|
chr1_-_171649002 Show fit | 1.49 |
ENSMUST00000111276.3
|
SLAM family member 7 |
|
chr11_-_79059872 Show fit | 1.46 |
ENSMUST00000141409.1
|
kinase suppressor of ras 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 15.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 3.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 2.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 2.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 1.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.5 | 1.6 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.5 | 1.5 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.1 | 1.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 1.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 1.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 2.5 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 1.5 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.9 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.7 | GO:0043539 | insulin-like growth factor receptor binding(GO:0005159) protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 3.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.6 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.1 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.1 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 15.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 15.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 4.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |